Fig. 1From: Breast cancer PAM50 signature: correlation and concordance between RNA-Seq and digital multiplexed gene expression technologies in a triple negative breast cancer seriesPAM50 subtype calls by technique. Barplot represents counts of samples per subtype and technique. The cross table shows in detail the discordances between both platformsBack to article page